Skip to main content

International Trade Law

Learning Objectives​

By the end of this page, you should be able to:

  1. Define international trade law and situate the WTO within it.
  2. Explain the two pillars of non-discrimination — Most-Favoured-Nation treatment and National Treatment — and their main exceptions.
  3. Describe the WTO dispute settlement process and its current appellate crisis.
  4. Identify the Indian statutes implementing trade obligations: the Customs Act 1962, the Foreign Trade (Development and Regulation) Act 1992, and FEMA 1999.
  5. Distinguish the three trade remedies — anti-dumping, countervailing, and safeguard duties — and say when each applies.
  6. Analyse real disputes involving India, including India — Solar Cells (WTO) and Novartis v. Union of India (TRIPS flexibilities).

Quick Answer​

International trade law is the body of rules governing cross-border commerce in goods, services, and intellectual property. Its multilateral core is the World Trade Organization (WTO, established 1995), whose agreements — GATT 1994 for goods, GATS for services, TRIPS for intellectual property — rest on two non-discrimination principles: treat all trading partners equally (Most-Favoured-Nation) and treat imported goods no worse than domestic ones (National Treatment). India, a founding WTO member, implements these obligations through domestic statutes: the Customs Act 1962 (tariffs and valuation), the Foreign Trade (Development and Regulation) Act 1992 (import-export policy), and FEMA 1999 (cross-border payments). Because India is dualist, WTO rules bind India internationally but reach Indian courts only through this legislation.

Overview​

Why does trade need international law at all? Because tariffs and trade barriers are classic prisoner's-dilemma territory: every state gains from open markets abroad but is tempted to protect its own. Trade law converts unilateral temptation into reciprocal, enforceable commitments — states "bind" their maximum tariffs in schedules and accept adjudication when they cheat.

The system has three layers a student must keep distinct:

  1. Multilateral — the WTO agreements, binding on all 160-plus members.
  2. Regional and bilateral — free trade agreements (FTAs), such as India's agreements with ASEAN, Japan, UAE (CEPA 2022), and Australia (ECTA 2022), permitted as exceptions to MFN under GATT Article XXIV.
  3. National — the domestic statutes and authorities (in India: the DGFT, Customs, the Directorate General of Trade Remedies) that actually operate at the border.

Public international trade law (state-to-state, this page) should also be distinguished from the private law of international sales (contracts between traders, CISG, INCOTERMS) — a common exam confusion.

Core Concepts​

1. The WTO and Its Agreements​

Definition: The World Trade Organization is the international organisation, established by the Marrakesh Agreement (1994, in force 1 January 1995), that administers the multilateral trade agreements, provides a negotiation forum, and operates a binding dispute settlement system.

Explanation: The WTO replaced the provisional GATT 1947 regime after the Uruguay Round (1986–94). Its structure is a "single undertaking": joining means accepting the whole package — GATT 1994 (goods), GATS (services), TRIPS (intellectual property), plus specialised agreements on agriculture, sanitary and phytosanitary measures (SPS), technical barriers to trade (TBT), subsidies (SCM), anti-dumping, and the Dispute Settlement Understanding (DSU). Decision-making is by consensus; the Ministerial Conference is the top organ. India was a founding member of both GATT (1948) and the WTO (1995).

Example: When India joined the WTO it accepted TRIPS, which required amending the Patents Act 1970 to allow product patents on pharmaceuticals — completed by the Patents (Amendment) Act, 2005, after using the full transition period allowed to developing countries.

Real-World Example: In India — Quantitative Restrictions (DS90, 1999), the US successfully challenged India's balance-of-payments import restrictions; India complied by phasing out quantitative restrictions by 2001 — a direct example of WTO law reshaping Indian import policy.

Why It Matters: Almost every question in this subject — tariffs, dumping, IP, disputes — runs through the WTO framework. Knowing the agreement that governs each subject-matter is the first analytical step.

Common Misunderstanding: Students often write that the WTO "sets tariffs." It does not — each member negotiates and binds its own maximum tariff rates in its schedule of concessions. The WTO's role is to hold members to what they promised, not to dictate rates.

2. Non-Discrimination: MFN and National Treatment​

Definition: Most-Favoured-Nation treatment (GATT Article I) requires a member to extend, immediately and unconditionally, any trade advantage given to one country to all other members. National Treatment (GATT Article III) requires imported products, once they have cleared customs, to be treated no less favourably than like domestic products in internal taxes and regulations.

Explanation: MFN operates at the border between foreign suppliers (no playing favourites among trading partners); National Treatment operates inside the market (no using internal taxes or rules as disguised protection). Both apply to "like products" — likeness is judged by physical characteristics, end uses, consumer tastes, and tariff classification. Key exceptions: Article XXIV (customs unions and FTAs may discriminate in favour of their members), the Enabling Clause (preferences for developing countries, e.g. GSP schemes), Article XX general exceptions (public morals, health, exhaustible natural resources — subject to the chapeau's ban on arbitrary discrimination), and Article XXI security exceptions.

Example: If India lowers its tariff on Japanese machine tools to 5% under no FTA, MFN obliges it to charge 5% on like machine tools from every WTO member. But the 5% preferential rate India gives UAE goods under the CEPA is lawful discrimination sheltered by Article XXIV.

Real-World Example: In India — Solar Cells (DS456, 2016), the US challenged the domestic content requirements of India's National Solar Mission, which obliged solar power developers to use Indian-made cells and modules. The WTO Appellate Body held this violated National Treatment (GATT Article III:4 and TRIMs Article 2.1) — imported cells were treated less favourably than domestic ones — and India's Article XX defences failed.

Why It Matters: MFN and National Treatment are the doctrinal heart of the subject; virtually every dispute begins by asking which non-discrimination norm is engaged and whether an exception saves the measure.

Common Misunderstanding: Confusing the two norms. Shortcut: MFN compares foreigner with foreigner; National Treatment compares foreigner with local. A measure can violate one without the other.

3. Tariffs, Trade Remedies, and the Indian Machinery​

Definition: Tariffs are duties on imports, capped by each member's bound rates; trade remedies are the three lawful shields against injurious imports — anti-dumping duties (against exports priced below normal value), countervailing duties (against subsidised imports), and safeguard measures (against sudden import surges).

Explanation: Each remedy has distinct triggers. Dumping (GATT Article VI and the Anti-Dumping Agreement) is price discrimination by exporters: export price below "normal value" (home-market price); the remedy requires proof of dumping, material injury to the domestic industry, and a causal link. Countervailing duties (SCM Agreement) offset foreign government subsidies. Safeguards (Article XIX and the Safeguards Agreement) respond to fair but overwhelming import surges causing serious injury — because the trade is fair, safeguards must apply on an MFN basis and may require compensation. In India, the Directorate General of Trade Remedies (DGTR, under the Commerce Ministry) investigates and recommends; the Finance Ministry imposes duties under Sections 9A (anti-dumping), 9 (countervailing), and 8B (safeguard) of the Customs Tariff Act, 1975. Ordinary customs duties are levied under the Customs Act, 1962, with transaction-value based valuation under Section 14.

Example: Chinese solar glass sells in China at Rs 100/unit but is exported to India at Rs 70. If Indian producers show material injury caused by these imports, the DGTR can recommend an anti-dumping duty of up to the dumping margin (Rs 30).

Real-World Example: India is one of the world's most frequent users of anti-dumping measures, with hundreds of duties imposed since 1995 — heavily on chemicals, steel, and Chinese products. In 2020–21 India also imposed safeguard-style tariff measures on solar imports (a basic customs duty from April 2022) after the WTO ruling closed the domestic-content route.

Why It Matters: Trade remedies are where international trade law becomes daily legal practice in India — DGTR proceedings, CESTAT appeals, and writ petitions form a substantial practice area.

Common Misunderstanding: That dumping is illegal per se. It is not — dumping is private firms' pricing conduct, which the WTO does not prohibit. The law only permits the importing state to respond with duties if injury is proved. Similarly, not all subsidies are prohibited: the SCM Agreement bans export subsidies and import-substitution subsidies, while others are merely actionable if they injure.

4. WTO Dispute Settlement​

Definition: The compulsory state-to-state adjudication system under the Dispute Settlement Understanding (DSU): consultations, then a panel, then (in principle) appeal to the Appellate Body, with authorised retaliation as the ultimate enforcement tool.

Explanation: The sequence: (1) consultations (minimum 60 days); (2) panel of three experts, established quasi-automatically by "reverse consensus" — the report is adopted unless all members, including the winner, vote against it; (3) appeal on issues of law to the seven-member Appellate Body; (4) implementation within a "reasonable period"; (5) failing compliance, compensation or DSB-authorised suspension of concessions (retaliation). This reversed the old GATT system where the losing party could block adoption. Since December 2019, however, the Appellate Body has been paralysed: the United States has blocked all appointments, leaving it without a quorum, so appeals now go "into the void" unless parties use the interim MPIA arbitration arrangement (India is not an MPIA participant).

Example: If State A's measure is held WTO-inconsistent and A refuses to comply, the winning state B may be authorised to raise tariffs on A's exports up to the level of harm suffered — lawful, calibrated retaliation.

Real-World Example: India has been an active litigant: complainant in US — Shrimp/Turtle era disputes and in challenges to US steel tariffs; respondent in India — Patents (Mailbox) (DS50, 1998, TRIPS transition obligations), India — Quantitative Restrictions (DS90), India — Solar Cells (DS456), and India — Export Related Measures (DS541, panel found several Indian export subsidy schemes prohibited; under appeal into the void).

Why It Matters: The DSU was called the "crown jewel" of the WTO — the most used inter-state adjudication system in history (600+ disputes). Its current crisis is a standard essay topic on the limits of international adjudication.

Common Misunderstanding: That the WTO can "fine" states or strike down national laws. It cannot — a ruling obliges the member to bring its measure into conformity; the sanction for refusal is authorised retaliation by the injured member, nothing more. The domestic law remains valid domestically until the state itself changes it.

5. TRIPS and India: Trade Meets Intellectual Property​

Definition: The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) sets minimum global standards for patents, trademarks, copyrights, and other IP, enforced through WTO dispute settlement — the first time IP was tied to the trade regime.

Explanation: TRIPS required patents in "all fields of technology" for 20 years (Article 27), forcing India to abandon its process-patent-only regime for medicines (a deliberate choice of the Patents Act 1970 that had built India's generic industry). India used the developing-country transition until 2005 with a "mailbox" for pharmaceutical applications. Crucially, TRIPS contains flexibilities: compulsory licensing (Article 31), the Doha Declaration on TRIPS and Public Health (2001) affirming members' right to protect public health, and freedom to define patentability standards — which India used in Section 3(d) of the Patents Act (barring evergreening of known substances without enhanced efficacy).

Example: In 2012 India granted its first compulsory licence (Natco v. Bayer) for the cancer drug Nexavar, allowing generic manufacture at a fraction of the patented price on grounds including non-affordability — a textbook use of Article 31 flexibility.

Real-World Example: In Novartis AG v. Union of India (2013), the Supreme Court upheld the rejection of Novartis's patent for the beta-crystalline form of imatinib mesylate (Glivec) under Section 3(d), holding TRIPS leaves members free to set higher efficacy thresholds. The judgment is the global reference point for TRIPS flexibilities in access-to-medicines debates.

Why It Matters: TRIPS is where international trade law visibly touches life-and-death policy — drug prices, vaccine access (the COVID-19 TRIPS waiver debate, in which India and South Africa led the waiver proposal in 2020).

Common Misunderstanding: That TRIPS imposes one uniform patent law worldwide. It sets minimum standards and leaves genuine policy space — Section 3(d) and compulsory licensing are TRIPS-compliant, as Novartis confirms, not violations that India "gets away with."

Visual Learning​

The architecture of the system and the path of a WTO dispute:

Key Terms​

TermDefinitionContext
MFN (Most-Favoured-Nation)Any advantage to one member must go to all membersGATT Art I; exceptions: FTAs (Art XXIV), Enabling Clause
National TreatmentImports treated no less favourably than like domestic products internallyGATT Art III; breached in India — Solar Cells
Bound tariffMaximum tariff a member has committed in its scheduleApplied rates may be lower; exceeding the binding violates Art II
DumpingExporting below normal (home-market) valueNot illegal per se; duties need dumping + injury + causation
Countervailing dutyDuty offsetting a foreign subsidySCM Agreement; s.9 Customs Tariff Act 1975
SafeguardTemporary MFN-basis protection against fair import surgesGATT Art XIX; "serious injury" — a higher bar than material injury
DSU / DSBDispute Settlement Understanding / BodyReverse consensus makes adoption quasi-automatic
Appellate Body crisisUS block on appointments left the AB without quorum (Dec 2019)Appeals "into the void"; MPIA is the interim workaround
TRIPS flexibilitiesCompulsory licensing, patentability standards, Doha Declaration 2001India: s.3(d) Patents Act; Novartis (2013); Natco/Bayer licence
DGTRDirectorate General of Trade Remedies (India)Investigates dumping/subsidy/safeguard cases; Finance Ministry imposes duties
FTDR Act 1992Foreign Trade (Development and Regulation) ActBasis of India's Foreign Trade Policy; DGFT licensing; replaced the Imports & Exports (Control) Act 1947
FEMA 1999Foreign Exchange Management ActCivil regime for cross-border payments; replaced the criminal-flavoured FERA 1973

Common Mistakes​

Mistake 1: "Dumping and subsidies are banned by the WTO, so dumped goods are illegal imports." Why it's wrong: Dumping is private pricing behaviour the WTO does not and cannot prohibit; most subsidies are also lawful. The agreements only discipline the response of the importing state and the worst categories of subsidy (export and import-substitution subsidies). Correct approach: Frame the analysis as: has the importing state proved dumping/subsidisation + injury + causation through a proper investigation? Only then may it impose duties, capped at the dumping margin or subsidy amount.

Mistake 2: "A WTO ruling automatically invalidates the offending national law." Why it's wrong: WTO law operates on the international plane. India's domestic content requirements did not vanish when the Appellate Body ruled in India — Solar Cells; India had to change its policy itself. Domestic courts do not enforce WTO rulings directly (India is dualist). Correct approach: State the compliance sequence — reasonable period, compensation, authorised retaliation — and note that implementation is always an act of the losing member, not of the WTO.

Mistake 3: "FTAs violate MFN, so India's CEPA and ECTA agreements are WTO-inconsistent." Why it's wrong: GATT Article XXIV expressly permits customs unions and free trade areas that eliminate duties on "substantially all trade" between members; the Enabling Clause separately permits preferences among developing countries. Correct approach: Treat FTAs as a lawful, conditioned exception to MFN — and be ready to discuss the policy tension (the "spaghetti bowl" of overlapping FTAs eroding multilateralism) as an analysis point.

Comparison and Connections​

AspectAnti-dumping dutyCountervailing dutySafeguard measure
TargetsBelow-normal-value pricing by exportersForeign government subsidiesFair but sudden import surges
Injury standardMaterial injuryMaterial injurySerious injury (higher)
Applied toSpecific exporters/countriesSubsidising countryAll sources (MFN basis)
Indian provisions.9A Customs Tariff Act 1975s.9s.8B
Compensation owed?NoNoPossibly, after 3 years
Frequently confused pairDistinction
MFN vs National TreatmentForeigner-vs-foreigner (border) vs foreigner-vs-local (internal measures)
GATT 1947 vs WTOProvisional treaty with blockable rulings vs permanent organisation with reverse-consensus adjudication
Public trade law vs private trade lawState obligations (WTO) vs trader contracts (CISG, INCOTERMS — India is not a CISG party)
Bound rate vs applied rateCeiling promised at the WTO vs rate actually charged (can be lower, never lawfully higher)
FERA 1973 vs FEMA 1999Criminal, control-oriented regime vs civil, management-oriented regime

Connections: this topic extends International Economic Law (which adds investment law and the IMF/World Bank), uses treaty interpretation from Treaties, and its dispute system contrasts instructively with the consent-based ICJ covered in International Courts.

Practice Questions​

Recall​

  1. Name the three principal WTO agreements and the subject each governs. Answer guidance: GATT 1994 — trade in goods; GATS — trade in services; TRIPS — intellectual property. Add the DSU (disputes) and the single-undertaking point for extra credit.

  2. Which Indian statutory provisions authorise anti-dumping, countervailing, and safeguard duties, and which body investigates? Answer guidance: Customs Tariff Act 1975 — s.9A (anti-dumping), s.9 (countervailing), s.8B (safeguards); investigation by the DGTR, imposition by the Ministry of Finance.

Understanding​

  1. Explain the difference between MFN and National Treatment with one example of each. Answer guidance: Define both (GATT Arts I and III), give the foreigner-foreigner vs foreigner-local comparison, illustrate MFN with tariff rates across partners and NT with an internal tax or content requirement (India — Solar Cells), and name at least one exception to each.

  2. Why is "reverse consensus" considered the key innovation of the WTO dispute system over GATT 1947? Answer guidance: Under GATT 1947 reports needed positive consensus, letting losers block adoption. Under the DSU a report is adopted unless everyone objects — making adjudication quasi-automatic and rulings effectively binding. Then note the irony of the current Appellate Body paralysis restoring blockability by another route.

Application​

  1. India requires all electric-vehicle charging stations receiving government subsidies to use Indian-made chargers. A WTO member whose manufacturers are shut out asks for advice. Answer guidance: Mirror India — Solar Cells: a domestic content requirement conditioning an advantage on using local goods violates GATT Art III:4 and TRIMs Art 2.1. Test possible defences: Art XX(j) (short supply) and XX(d) failed in DS456; government procurement for the state's own use (Art III:8(a)) is the one arguable carve-out — did the government purchase the chargers or merely subsidise private buyers? Outline DSU steps.

  2. Cheap imports of a fairly traded, unsubsidised product surge into India after a global glut, threatening domestic producers. Which trade remedy fits, and what conditions apply? Answer guidance: Neither anti-dumping (no below-value pricing) nor CVD (no subsidy) — this is safeguard territory: s.8B Customs Tariff Act / GATT Art XIX. Requirements: increased imports, serious injury or threat, causation; measure must be temporary, MFN-based, and may trigger compensation obligations.

Analysis​

  1. "The WTO dispute settlement system is the most successful international adjudication mechanism ever created — and it is currently broken." Discuss. Answer guidance: Success metrics: 600+ disputes, high compliance, use by developing countries including India. Breakdown: US blocking AB appointments since 2019, appeals into the void, MPIA as partial fix, underlying critiques (judicial overreach claims, Art XXI security cases). Evaluate reform proposals and whether panel-stage adjudication plus negotiation suffices. A balanced conclusion scores best.

  2. Evaluate whether India's use of TRIPS flexibilities (Section 3(d), compulsory licensing) strikes the right balance between innovation incentives and access to medicines. Answer guidance: Present both sides: Novartis reasoning (efficacy threshold prevents evergreening; TRIPS permits it), the Natco/Bayer licence, Doha Declaration; against — pharma industry arguments on R&D incentives and investment signals, US Special 301 pressure. Anchor the legal conclusion (India is TRIPS-compliant) and keep the policy evaluation separate — examiners reward that separation.

FAQ​

Q1: Can an Indian company sue at the WTO if a foreign country blocks its exports? No. WTO dispute settlement is state-to-state only. The company must persuade the Government of India (Commerce Ministry) to bring the complaint — which is how most disputes actually begin, with affected industries lobbying their governments.

Q2: Is India bound by WTO rulings if it never enacted them into domestic law? Internationally, yes — rulings adopted by the DSB bind India as a matter of treaty obligation, and non-compliance risks authorised retaliation. Domestically, Indian courts apply Indian statutes, not WTO reports; but courts do try to interpret domestic law consistently with India's international obligations where the statute permits.

Q3: What is the difference between the WTO and free trade agreements like India's CEPA with the UAE? The WTO is the multilateral baseline binding all members on MFN terms. FTAs go further between their parties (often zero tariffs) and are permitted as exceptions to MFN under GATT Article XXIV if they cover substantially all trade. India has increasingly pursued FTAs (UAE CEPA and Australia ECTA, both 2022) as multilateral negotiations have stalled.

Q4: Why did India oppose including labour and environmental standards in the WTO? India and many developing countries argue such standards can become disguised protectionism — richer countries using them to offset developing-country cost advantages — and that the ILO and environmental treaties are the proper forums. The debate resurfaces with carbon border taxes (like the EU's CBAM), which India contends discriminate against developing-country exports.

Q5: Does the collapse of the Appellate Body mean WTO law no longer binds anyone? No. The substantive obligations remain binding, panels still function, and most disputes still settle or lead to compliance. What is lost is guaranteed appellate review: a losing party can appeal "into the void" and stall adoption. Some members created the MPIA (interim appeal arbitration) as a stopgap; India has not joined it, preferring restoration of the Appellate Body.

Quick Revision​

  • International trade law = rules on cross-border goods, services, and IP; multilateral core = WTO (Marrakesh Agreement, in force 1995; India a founding member).
  • Three pillars: GATT 1994 (goods), GATS (services), TRIPS (IP) — accepted as a single undertaking.
  • MFN (GATT Art I): equal treatment among foreign partners; National Treatment (Art III): imports vs domestic products. Exceptions: Art XX (general), Art XXI (security), Art XXIV (FTAs), Enabling Clause.
  • Dumping ≠ illegal; remedy needs dumping + material injury + causation. Safeguards need serious injury and apply MFN-wide.
  • India's machinery: Customs Act 1962 (s.14 valuation), Customs Tariff Act 1975 (ss. 8B/9/9A), FTDR Act 1992 (DGFT, Foreign Trade Policy), FEMA 1999 (civil forex regime, replaced FERA).
  • DGTR investigates trade remedies; Finance Ministry imposes duties.
  • DSU: consultations → panel → Appellate Body → compliance → retaliation; adoption by reverse consensus; AB paralysed since Dec 2019 (US blocking appointments).
  • India's key disputes: QRs (DS90 — lost, removed import restrictions), Solar Cells (DS456 — domestic content requirements violated NT/TRIMs), Export Measures (DS541).
  • TRIPS: 20-year product patents; India complied in 2005 but kept flexibilities — s.3(d) upheld in Novartis (2013); first compulsory licence: Natco/Bayer (2012, Nexavar).
  • India is dualist: WTO obligations reach courts only via implementing statutes.
  • India is not a party to the CISG (private sales law) — don't confuse it with WTO law.

Prerequisites​

Next Topics​